Drug Trial Radar · NCT01595061
Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva
Last checked: Nov 19, 2026Latest source record: Dec 29, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
57
Actual
Start
Jul 2, 2012
Primary completion
Sep 23, 2020
Study completion Sep 23, 2022
Sponsor
- Lead sponsor
- Gynecologic Oncology GroupResearch network
- Sponsor type
- Research network
- Collaborators
- National Cancer Institute (NCI)
- First posted
- May 9, 2012
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase II trial studies how well radiation therapy works when given with gemcitabine hydrochloride and cisplatin work in treating patients with squamous cell cancer of the vulva that has spread from where it started to nearby tissue or lymph nodes. Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as gemcitabine hydrochloride and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving radiation therapy together with gemcitabine hydrochloride and cisplatin may kill more tumor cells.
Conditions
- Stage III Vulvar Cancer AJCC v7
- Stage IIIA Vulvar Cancer AJCC v7
- Stage IIIB Vulvar Cancer AJCC v7
- Stage IIIC Vulvar Cancer AJCC v7
- Stage IVA Vulvar Cancer AJCC v7
- Vulvar Squamous Cell Carcinoma
Interventions
CisplatinDrug
Given IV
Gemcitabine HydrochlorideDrug
Given IV
Intensity-Modulated Radiation TherapyRadiation
Undergo IMRT
Therapeutic Conventional SurgeryProcedure
Undergo local core biopsy or surgical excision
Primary outcomes
What the sponsor says the trial is designed to measure.
- Complete Pathologic ResponseTime frame: 6 -8 weeks after completion of chemo-radiation
Locations
193 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama at Birmingham Cancer Center
Birmingham, Alabama
Anchorage Associates in Radiation Medicine
Anchorage, Alaska
Anchorage Radiation Therapy Center
Anchorage, Alaska
Alaska Breast Care and Surgery LLC
Anchorage, Alaska
Alaska Oncology and Hematology LLC
Anchorage, Alaska
Alaska Women's Cancer Care
Anchorage, Alaska
Anchorage Oncology Centre
Anchorage, Alaska
Katmai Oncology Group
Anchorage, Alaska
Providence Alaska Medical Center
Anchorage, Alaska
Providence Saint Joseph Medical Center/Disney Family Cancer Center
Burbank, California
UC Irvine Health/Chao Family Comprehensive Cancer Center
Orange, California
Hartford Hospital
Hartford, Connecticut
The Hospital of Central Connecticut
New Britain, Connecticut
Beebe Medical Center
Lewes, Delaware
Christiana Gynecologic Oncology LLC
Newark, Delaware
Delaware Clinical and Laboratory Physicians PA
Newark, Delaware
Helen F Graham Cancer Center
Newark, Delaware
Medical Oncology Hematology Consultants PA
Newark, Delaware
Christiana Care Health System-Christiana Hospital
Newark, Delaware
Beebe Health Campus
Rehoboth Beach, Delaware
TidalHealth Nanticoke / Allen Cancer Center
Seaford, Delaware
Christiana Care Health System-Wilmington Hospital
Wilmington, Delaware
Augusta University Medical Center
Augusta, Georgia
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
Savannah, Georgia
The Cancer Center of Hawaii-Pali Momi
‘Aiea, Hawaii
Queen's Medical Center
Honolulu, Hawaii
University of Hawaii Cancer Center
Honolulu, Hawaii
The Cancer Center of Hawaii-Liliha
Honolulu, Hawaii
Kapiolani Medical Center for Women and Children
Honolulu, Hawaii
Saint Luke's Cancer Institute - Boise
Boise, Idaho
Saint Luke's Cancer Institute - Fruitland
Fruitland, Idaho
Saint Luke's Cancer Institute - Meridian
Meridian, Idaho
Saint Luke's Cancer Institute - Nampa
Nampa, Idaho
Saint Luke's Cancer Institute - Twin Falls
Twin Falls, Idaho
Rush - Copley Medical Center
Aurora, Illinois
Saint Joseph Medical Center
Bloomington, Illinois
Illinois CancerCare-Bloomington
Bloomington, Illinois
Illinois CancerCare-Canton
Canton, Illinois
Memorial Hospital of Carbondale
Carbondale, Illinois
SIH Cancer Institute
Carterville, Illinois
Showing 40 of 193 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.